Primary Site >> Stomach Cancer

Gene >> EPHA2

  • 2003
  • 2005
  • 2009
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.
PMID: 14679012
 Ref: EPHA2/EFNA1 expression in human gastric cancer.
PMID: 15649254
 Ref: Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis.
PMID: 19048396
 Ref: Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo.
PMID: 22103904
Ref: Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.
PMID: 22189617
Ref: Multidimensional identification of tissue biomarkers of gastric cancer.
PMID: 22533479
 Ref: EphA4 is a prognostic factor in gastric cancer.
PMID: 23738943
 Ref: EphA2 promotes epithelial-mesenchymal transition through the Wnt/beta-catenin pathway in gastric cancer cells.
PMID: 23752181
Ref: MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.
PMID: 25063221
Ref: Geldanamycin mediates the apoptosis of gastric carcinoma cells through inhibition of EphA2 protein expression.
PMID: 25310629
Ref: Prognostic role of EphA2 in various human carcinomas: a meta-analysis of 23 related studies.
PMID: 25418013
Ref: Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.
PMID: 25455899
 Ref: Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer.
PMID: 24908114
 Ref: Novel anti-EPHA2 antibody, DS-8895a for cancer treatment.
PMID: 27653549
Ref: To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients.
PMID: 27994652
 Ref: EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells.
PMID: 28624791
Ref: Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer.
PMID: 29072678
Ref: miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ beta-catenin/EMT signaling cascade in gastric cancer.
PMID: 29273006
 Ref: Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer.
PMID: 29491103
Ref: Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.
PMID: 29948146
Ref: The relationship between miR-302b and EphA2 and their clinical significance in gastric cancer.
PMID: 30210634